Pheno.AI

Phenotype Multi-omics Datasets to Improve Human Health

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo Founded 2021
Total raised
Last: SAFE 2024-11
Stage
Seed
Founded
2021
Headcount
44
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

Pheno.AI's mission is to improve human health by collecting, organizing and making accessible the world's largest collection of deep-phenotype multi-omics datasets, and by enabling others to do the same.

The datasets were collected by a multi-disciplinary team of scientists & researchers as part of the Human Phenotype Project - a landmark global effort that set out to collect the world's deepest phenotype, multi-omic datasets. The 25-year longitudinal study launched in 2018 and has enrolled 20k participants to date.

Pheno.AI workspace is compliant with the highest security standards, and enables members to collaborate with their team. Its compute resources can be adjusted to meet your research needs.

Funding history · 2 rounds · — total

2024-11
SAFE Undisclosed
2022-06
Seed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Pheno.AI founded?
Pheno.AI was founded in March 2021.
Where is Pheno.AI headquartered?
Pheno.AI is headquartered in Tel Aviv-Yafo, Israel.
What is Pheno.AI's primary mission?
Pheno.AI's mission is to improve human health by collecting, organizing, and making accessible the world's largest collection of deep-phenotype multi-omics datasets.
How many employees does Pheno.AI currently have?
Pheno.AI currently has 44 employees.
Which investors participated in Pheno.AI's Seed funding round?
Pheno.AI's Seed funding round in June 2022 included Entrée Capital as a lead investor.
Which investor participated in Pheno.AI's SAFE funding round?
Pheno.AI's SAFE funding round in November 2024 included Corundum Neuroscience.
What is the Human Phenotype Project mentioned by Pheno.AI?
The Human Phenotype Project is a 25-year longitudinal study launched in 2018 that has enrolled 20,000 participants to collect deep phenotype, multi-omic datasets, which Pheno.AI utilizes.
What was a recent development involving Pheno.AI, Nvidia, and the Weizmann Institute?
In November 2024, Nvidia, the Weizmann Institute, and Pheno.AI collaborated to develop a glucose monitoring model.
Who is a founder of Pheno.AI?
Ori Cohen is a founder of Pheno.AI.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Platforms & InterfacesSearch Engine
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcareLaboratoriesProviders
Business model
B2B

Tags

biomarkersdigital-healthcaredrug-developmentclinical-trialsdisease-managementdrug-discoverydecision-support